Nielsen VK (1984) Pathophysiology of hemifacial spasm: I Ephaptic transmission and ectopic excitation. Neurology 34(4):418–418

Article  CAS  PubMed  Google Scholar 

Auger RG (1979) Hemifacial spasm: clinical and electrophysiologic observations. Neurology 29(9 Part 1):1261–1261

Article  CAS  PubMed  Google Scholar 

Kameyama S et al (2016) Ephaptic transmission is the origin of the abnormal muscle response seen in hemifacial spasm. Clin Neurophysiol 127(5):2240–2245

Article  PubMed  Google Scholar 

Ferguson JH (1978) Hemifacial spasm and the facial nucleus. Annals Neurol: Official J Am Neurological Assoc Child Neurol Soc 4(2):97–103

Article  CAS  Google Scholar 

Ogawara K et al (2004) Trigeminal afferent input alters the excitability of facial motoneurons in hemifacial spasm. Neurology 62(10):1749–1752

Article  CAS  PubMed  Google Scholar 

Møller AR (1991) Interaction between the blink reflex and the abnormal muscle response in patients with hemifacial spasm: results of intraoperative recordings. J Neurol Sci 101(1):114–123

Article  PubMed  Google Scholar 

Wilkinson MF, Kaufmann AM (2014) Facial motor neuron excitability in hemifacial spasm: a facial MEP study. Can J Neurol Sci 41(2):239–245

Article  PubMed  Google Scholar 

Valls-Sole J, Tolosa ES (1989) Blink reflex excitability cycle in hemifacial spasm. Neurology 39(8):1061–1061

Article  CAS  PubMed  Google Scholar 

Pavesi G et al (2003) Trigemino-facial inhibitory reflexes in idiopathic hemifacial spasm. Mov Disord 18(5):587–592

Article  PubMed  Google Scholar 

Yaltho TC, Jankovic J (2011) The many faces of hemifacial spasm: differential diagnosis of unilateral facial spasms. Mov Disord 26(9):1582–1592

Article  PubMed  Google Scholar 

Wabbels B, Roggenkämper P (2012) Botulinum toxin in hemifacial spasm: the challenge to assess the effect of treatment. J Neural Transm 119:963–980

Article  CAS  PubMed  Google Scholar 

Giladi N (1997) The mechanism of action of botulinum toxin type A in focal dystonia is most probably through its dual effect on efferent (motor) and afferent pathways at the injected site. J Neurol Sci 152(2):132–135

Article  CAS  PubMed  Google Scholar 

Currà A et al (2004) Central effects of botulinum toxin type A: evidence and supposition. Mov Disord: Official J Mov Disord Soc 19(S8):S60–S64

Article  Google Scholar 

Luvisetto S (2021) Botulinum neurotoxins in central nervous system: An overview from animal models to human therapy. Toxins 13(11):751

Article  CAS  PubMed  PubMed Central  Google Scholar 

Samotus O, Chen R, Jog M (2021) Changes in cortical excitability and Parkinson tremor after botulinum toxin therapy. Neurology 97(14):e1413–e1424

Article  CAS  PubMed  Google Scholar 

Palomar FJ, Mir P (2012) Neurophysiological changes after intramuscular injection of botulinum toxin. Clin Neurophysiol 123(1):54–60

Article  CAS  PubMed  Google Scholar 

Boroojerdi B, Cohen LG, Hallett M (2003) Effects of botulinum toxin on motor system excitability in patients with writer’s cramp. Neurology 61(11):1546–1550

Article  CAS  PubMed  Google Scholar 

Weise D, Weise CM, Naumann M (2019) Central effects of botulinum neurotoxin—evidence from human studies. Toxins 11(1):21

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mazzocchio R, Caleo M (2015) More than at the neuromuscular synapse: actions of botulinum neurotoxin A in the central nervous system. Neuroscientist 21(1):44–61

Article  PubMed  Google Scholar 

Girlanda P et al (1996) Unilateral injection of botulinum toxin in blepharospasm: single fiber electromyography and blink reflex study. Mov Disord: Official J Mov Disord Soc 11(1):27–31

Article  CAS  Google Scholar 

Ce P (2000) Central effects of botulinum toxin: study of brainstem auditory evoked potentials. Eur J Neurol 7(6):747–747

Article  CAS  PubMed  Google Scholar 

Behari M, Raju G (1996) Electrophysiological studies in patients with blepharospasm before and after botulinum toxin A therapy. J Neurol Sci 135(1):74–77

Article  CAS  PubMed  Google Scholar 

Conte A et al (2010) Electrical activation of the orbicularis oculi muscle does not increase the effectiveness of botulinum toxin type A in patients with blepharospasm. Eur J Neurol 17(3):449–455

Article  CAS  PubMed  Google Scholar 

Kim B, Lee W, Kim M (1998) Blink reflex in patients with hemifacial spasm before and after botulinum toxin treatment. Korean J Neurol 16(6):859–865

Google Scholar 

Mir P et al (2006) Alteration of central motor excitability in a patient with hemimasticatory spasm after treatment with botulinum toxin injections. Mov Disord: Official J Mov Disord Soc 21(1):73–78

Article  Google Scholar 

Ishikawa M et al (2010) Treatment with botulinum toxin improves the hyperexcitability of the facial motoneuron in patients with hemifacial spasm. Neurol Res 32(6):656–660

Article  CAS  PubMed  Google Scholar 

Peng B et al (2015) Clinical and electrophysiological studies of botulinum toxin type A to treat hemifacial spasm complicated with auricular symptoms. Int J Clin Exp Med 8(6):9772

PubMed  PubMed Central  Google Scholar 

Ferrazzano G et al (2015) Botulinum toxin and blink rate in patients with blepharospasm and increased blinking. J Neurol Neurosurg Psychiatry 86(3):336–340

Article  PubMed  Google Scholar 

Kimura J, Powers JM, Van Allen MW (1969) Reflex response of orbicularis oculi muscle to supraorbital nerve stimulation: study in normal subjects and in peripheral facial paresis. Arch Neurol 21(2):193–199

Article  CAS  PubMed  Google Scholar 

Kızıltan ME, Gunduz A (2018) Reorganization of sensory input at brainstem in hemifacial spasm and postparalytic facial syndrome. Neurol Sci 39:313–319

Article  PubMed  Google Scholar 

Quartarone A et al (2006) Enhanced long-term potentiation-like plasticity of the trigeminal blink reflex circuit in blepharospasm. J Neurosci 26(2):716–721

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hamjian JA, Walker FO (1994) Serial neurophysiological studies of intramuscular botulinum-A toxin in humans. Muscle Nerve: Official J Am Assoc Electrodiagnostic Med 17(12):1385–1392

Article  CAS  Google Scholar 

Sampaio C et al (1997) DYSBOT: a single-blind, randomized parallel study to determine whether any differences can be detected in the efficacy and tolerability of two formulations of botulinum toxin type A—Dysport and Botox—assuming a ratio of 4: 1. Mov Disord 12(6):1013–1018

Article  CAS  PubMed  Google Scholar